U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07001319) titled 'Study of GS-3242 in Participants With HIV-1' on May 23.
Brief Summary: This study is part of a master study. The goal of master protocol (GS-US-544-5905, NCT05585307) is to learn how novel antiretrovirals (medicines that stop the virus from multiplying) affect the human immunodeficiency virus-1 (HIV-1) infection in people living with HIV (PWH).
Substudy GS-US-544-5905-05 is to learn more about the study drug GS-3242 in PWH.
Study Start Date: June, 2025
Study Type: INTERVENTIONAL
Condition:
HIV-1-infection
Intervention:
DRUG: GS-3242
Administered orally
DRUG: BVY
Administered orally
DRUG: Standard of Care
Antiretroviral th...